NorMIGS - a Prospective Study of Micro-invasive Glaucoma Surgery
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
• Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS
• Ability to cooperate fairly well during the examinations
• Willing to participate in the study and capable of providing informed consent
Locations
Other Locations
Norway
Department of Ophthalmology, Oslo University Hospital
RECRUITING
Oslo
Contact Information
Primary
Olav Kristianslund, MD PhD
olakri@ous-hf.no
+4722118545
Time Frame
Start Date: 2022-04-22
Estimated Completion Date: 2028-06
Participants
Target number of participants: 100
Treatments
Group 1 Preserflo microshunt
Group 2 Trabeculectomy
Group 3 Other MIGS
Other micro-invasive glaucoma surgery (MIGS) than Preserflo microshunt (e.g., Xen gel stent, iStent inject)
Related Therapeutic Areas
Sponsors
Leads: Oslo University Hospital